DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
von Minckwitz G, Schwedler K, Schmidt M. et al
GBG 26/BIG 03-05 study group and participating investigators. Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
Eur J Cancer 2011;
47 (15) 2273-2281
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.